Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

Hannah Elizabeth Carter; Deborah Schofield; Rupendra Shrestha

doi:10.1136/openhrt-2018-000939

Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

Hannah Elizabeth Carter^*, Deborah Schofield, Rupendra Shrestha

^*Corresponding author for this work

Research output: Contribution to journal › Article

4 Citations (Scopus)

52 Downloads (Pure)

Abstract

Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.

Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.

Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95% CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87% of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.

Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.

Original language	English
Article number	e000939
Pages (from-to)	1-8
Number of pages	8
Journal	Open Heart
Volume	6
Issue number	1
DOIs	https://doi.org/10.1136/openhrt-2018-000939
Publication status	Published - 1 Feb 2019

Bibliographical note

Copyright Author(s) (or their employer(s)) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

heart failure
hypertensive heart disease
myocardial ischaemia and infarction (IHD)
peripheral vascular disease
public health

Access to Document

10.1136/openhrt-2018-000939Licence: CC BY-NC

Publisher version (open access)Final published version, 385 KBLicence: CC BY-NC

Fingerprint Dive into the research topics of 'Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups'. Together they form a unique fingerprint.

Projects

1 Finished

Long term economic impacts of disease on older workers to 2030: Costs to government and individuals and opportunities for intervention. [Funded by ARC Linkage Grant & Pfizer; Total Awarded: $834,700 LP100100158 ]

Schofield, D. & Passey, M. E.

1/01/09 → 31/12/11

Project: Research

Cite this

Carter, H. E., Schofield, D., & Shrestha, R. (2019). Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups. Open Heart, 6(1), 1-8. [e000939]. https://doi.org/10.1136/openhrt-2018-000939

@article{2a7107f7f22e44e78ede8fa7ae5232d7,

title = "Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups",

abstract = "Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95{\%} CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87{\%} of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.",

keywords = "heart failure, hypertensive heart disease, myocardial ischaemia and infarction (IHD), peripheral vascular disease, public health",

author = "Carter, {Hannah Elizabeth} and Deborah Schofield and Rupendra Shrestha",

note = "Copyright Author(s) (or their employer(s)) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2019",

month = "2",

day = "1",

doi = "10.1136/openhrt-2018-000939",

language = "English",

volume = "6",

pages = "1--8",

journal = "Open Heart",

issn = "2053-3624",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

AU - Carter, Hannah Elizabeth

AU - Schofield, Deborah

AU - Shrestha, Rupendra

N1 - Copyright Author(s) (or their employer(s)) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95% CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87% of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.

AB - Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95% CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87% of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.

KW - heart failure

KW - hypertensive heart disease

KW - myocardial ischaemia and infarction (IHD)

KW - peripheral vascular disease

KW - public health

UR - http://www.scopus.com/inward/record.url?scp=85062004478&partnerID=8YFLogxK

UR - http://purl.org/au-research/grants/arc/LP100100158

U2 - 10.1136/openhrt-2018-000939

DO - 10.1136/openhrt-2018-000939

M3 - Article

VL - 6

SP - 1

EP - 8

JO - Open Heart

JF - Open Heart

SN - 2053-3624

IS - 1

M1 - e000939

ER -